Search

everythinglearnresearchcommunity

for

Search:↓

Skin disease activity scores can help decide when skin symptoms no longer affect the quality of life in patients with mild dermatomyositis.

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

CEP135 may predict cancer outcomes, and targeting PLK1 could help treat certain sarcomas.

The combined therapy improved symptoms in PCOS patients.

Non-white organ transplant patients have worse skin cancer outcomes due to later diagnosis and treatment.

Patients should discuss complementary medicine use with doctors to improve health outcomes.

Tailored combination therapy improves non-scarring alopecia outcomes.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Using tissue expanders for scalp reconstruction in patients with extensive Aplasia Cutis Congenita is effective and has minimal complications.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

Understanding gender differences and individual patient characteristics is essential for optimal cosmetic surgery outcomes.

Trichoscopy helps better understand and manage alopecia areata, improving patient outcomes.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Nearly half of the patients had Long COVID, leading to health and work issues, especially in high-risk groups.

Personalized thiopurine dosing based on NUDT15 genotyping can improve long-term outcomes for ulcerative colitis and Crohn's disease patients.

Sex hormones likely did not affect COVID-19 outcomes in South Korea.

The study found that severe alopecia areata affects any age, treatments often give temporary results, and some factors predict worse outcomes.

Early detection of chemotherapy side effects allows treatment adjustments, improving patient outcomes.

Heavy metals like arsenic, cadmium, and lead can increase cancer risk and worsen outcomes.

Regular follow-up visits, especially with dermatologists, can lower death rates for melanoma patients, with socioeconomic factors also affecting outcomes.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Patients with autoimmune blistering diseases experience a reduced quality of life, with the need for better measurement tools, especially for those with mucous membrane pemphigoid.

People with hidradenitis suppurativa who are more resilient tend to have better quality of life and less anxiety and depression.

Reconstructing lower face gunshot injuries with a fibula and scalp flap is effective and gives good long-term results.

A patient with both bullous lichen planus and systemic lupus erythematosus showed improvement with treatment.

Many patients with autoimmune blistering skin disorders change their diets, avoiding foods like alcohol, citrus, and spices, and some find vegetables and dairy helpful.

The Blood Glucose Management Service improved patient safety and outcomes in managing blood sugar in hospitalized patients.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

Alitretinoin may cause irreversible hair curling as a side effect.

Long COVID recovery is hindered by smoking, with hair loss being a difficult symptom to treat.